Levi & Korsinsky Notifies Shareholders of a Complaint Filed in U.S. District Court to Recover Losses Suffered by Investors in Mallinckrodt plc (MNK)

NEW YORK, Jan. 24, 2017 -- Levi & Korsinsky, LLP announced that a class action has commenced in the USDC for the District of Columbia on behalf of purchasers of Mallinckrodt plc (NYSE:MNK) who purchased shares between November 25, 2014 through January 18, 2017.

The complaint alleges that throughout the Class Period Mallinckrodt and its Chief Executive Officer, Mark Trudeau, made a series of false and misleading statements and failed to disclose material adverse facts about the long-term sustainability of Mallinckrodt’s monopolistic HP Acthar Gel (“Acthar”) revenues and the exposure of Acthar to reimbursement rates by Medicare and Medicaid. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that Acthar’s monopoly status as the only FDA-approved adrenocorticotropic hormone preparation was the product of unlawful anticompetitive practices and failed to disclose that its increasing reliance on Medicare and Medicaid meant that Mallinckrodt’s monopolistic Acthar revenue would be threatened if the government took action to limit the price paid for this drug by taxpayers.

To get more information go to: http://www.zlk.com/pslra/mallinckrodt-plc

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Take Action: if you suffered a loss in Mallinckrodt you have until March 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky LLP encourages anyone with information regarding Mallinckrodt’s conduct to contact us, including whistleblowers, former employees, shareholders and others.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004     
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com